Encompass Health Corporation · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$121.71
+$1.50 (+1.25%) 2:59 PM ET
Prev closePrevC$120.21
OpenOpen$120.15
Day highHigh$122.51
Day lowLow$120.15
VolumeVol513,646
Avg volAvgVol908,216
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$11.86B
EV/Sales
2.32
P/E ratio
19.14
FY Revenue
$6.21B
EPS
6.28
Gross Margin
100.00%
Div yield
0.63%
Sector
Healthcare
AI report sections
MIXED
EHC
Encompass Health Corporation
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+31% (Above avg)
Vol/Avg: 1.31×
RSI
55.45(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
+0.04 (Strong)
MACD: 0.03 Signal: -0.01
Short-Term
-0.74 (Weak)
MACD: 1.83 Signal: 2.56
Long-Term
-0.48 (Weak)
MACD: 4.54 Signal: 5.03
Intraday trend score
50.00
LOW41.00HIGH68.00
Latest news
EHC•12 articles•Positive: 5Neutral: 1Negative: 6
NeutralThe Motley Fool• Jonathan Ponciano
What Three Encompass Health Insiders Selling Signals After a Rate Increase
Encompass Health's EVP and general counsel John Patrick Darby sold 8,906 shares (11% of his direct holdings) for $1.1 million on August 10, 2026, following strong earnings and a stock rally. The sale comes after the company raised guidance due to a favorable 2.3% Medicare rate increase for inpatient rehabilitation services starting in October. While multiple insiders trimmed positions after the earnings-driven rally, the article emphasizes that Medicare reimbursement rates are the key factor for investors to monitor, as they directly impact the company's pricing and profitability.
While the company received positive catalysts (strong earnings, raised guidance, favorable Medicare rate increase of 2.3%), insider selling by multiple executives after the stock rally suggests potential overvaluation concerns. The article notes that reimbursement rates are critical to monitor, indicating both upside and downside risks depending on future regulatory decisions. The neutral sentiment reflects the mixed signals of positive fundamentals offset by insider profit-taking.
PositiveThe Motley Fool• Jonathan Ponciano
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know
Encompass Health's CFO Douglas Coltharp sold 18,869 shares worth $2.4 million on August 10, reducing his direct stake by 27% but maintaining a total beneficial ownership of 241,000 shares valued at $30.4 million. The sale occurred the same day as the CEO's larger stake reduction, following strong Q2 earnings that included 10% revenue growth, raised full-year guidance, and increased dividend/buyback authorization.
Despite insider selling, the company reported strong Q2 results with 10% revenue growth, raised full-year guidance for the second time in 2026, and increased dividend/buyback authorization to $1 billion. The stock jumped to near 52-week highs on these results. The CFO's modest sale into strength appears routine rather than indicative of business concerns, and the company maintains solid operational metrics with $12.5B market cap and 10% net income margin.
PositiveInvesting.com• Chris Markoch
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
The healthcare sector added 35,200 jobs in May, with ambulatory services leading at 25,700 positions and hospitals adding 6,000. This consistent job growth signals sustained demand for healthcare services and revenue opportunities for companies positioned in ambulatory care, managed care, and inpatient rehabilitation. Three stocks are highlighted as beneficiaries of this trend: UnitedHealth Group, HCA Healthcare, and Encompass Health.
Core business benefits from growing post-acute and rehabilitation care demand. Q1 2026 results were exceptional with 9% revenue growth to $1.59B, adjusted EBITDA up 11.2%, and adjusted EPS surged 16.8%. Management raised full-year guidance, nurse turnover hit lowest level since 2012, and company is expanding with seven new hospitals in 2026. Analysts rate it Buy with $143.86 price target implying 40%+ upside.
PositiveBenzinga• Prnewswire
Encompass Health declares dividend on common stock
Encompass Health Corp. (NYSE: EHC) announced that its board of directors has declared a quarterly cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record on July 1, 2026. The company is the largest owner and operator of inpatient rehabilitation hospitals in the United States with 175 hospitals across 39 states and Puerto Rico.
The company's declaration of a quarterly dividend demonstrates financial strength and confidence in future cash flows. Dividend payments are generally viewed positively by investors as they represent a return of capital and indicate management's confidence in the company's ability to generate sustainable profits.
NegativeGlobeNewswire Inc.• Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Encompass Health Corporation – EHC
Pomerantz LLP is investigating potential securities fraud claims against Encompass Health Corporation following a New York Times article alleging that Encompass-owned for-profit hospitals perform below average on safety measures, with 34 facilities rated as having statistically significantly worse rates of preventable readmissions. The stock fell 10.35% following the publication.
The company faces securities fraud investigation following damaging New York Times report alleging poor safety records at its facilities, including high rates of preventable readmissions and patient fatalities. Stock declined 10.35% on the news, indicating significant investor concern about operational and compliance issues.
NegativeGlobeNewswire Inc.• Pomerantz Llp
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
Pomerantz LLP announced investigations into potential securities fraud at Confluent, GoDaddy, and Encompass Health. The investigation into Confluent was triggered by the company's disclosure that a major AI-native customer is reducing spending, which caused the stock to plunge 32.86% on July 31, 2025. Investors are being solicited to join class action lawsuits against these companies.
Subject of securities fraud investigation by Pomerantz LLP, though specific details are not provided in the article excerpt.
NegativeGlobeNewswire Inc.• Portnoy Law Firm
Encompass Health Corporation Investigated by the Portnoy Law Firm
The Portnoy Law Firm has initiated an investigation into possible securities fraud at Encompass Health Corporation following a July 15, 2025 New York Times report alleging that the company's for-profit hospitals perform below average on key safety measures. The report highlighted alarming mistakes leading to patient fatalities and noted that 34 Encompass facilities had statistically significantly worse rates of potentially preventable readmissions. Encompass's stock fell 10.4% to $107.28 per share following the disclosure.
The company faces a securities fraud investigation following damaging media reports about poor safety measures, patient fatalities, and high preventable readmission rates at 34 facilities. The stock price declined 10.4% on the news, indicating significant investor concern and potential financial liability from class action litigation.
PositiveBenzinga• Prnewswire
Encompass Health declares dividend on common stock
Encompass Health Corp. (NYSE: EHC) announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on April 15, 2026, to shareholders of record on April 1, 2026.
The declaration of a quarterly dividend demonstrates the company's financial strength and confidence in its cash flow generation. Dividend payments are generally viewed positively by investors as they represent a return of capital and indicate management's confidence in the company's ability to sustain operations while rewarding shareholders.
NegativeGlobeNewswire Inc.• Rosen Law Firm
EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims for Encompass Health shareholders following a New York Times article alleging serious patient safety incidents in their rehabilitation hospitals.
The New York Times article reported rare but serious patient harm incidents and below-average safety performance in Encompass Health's rehabilitation hospitals, causing a 10.3% stock price drop and potential legal investigation
PositiveBenzinga• Prnewswire
Encompass Health declares dividend on common stock
Encompass Health Corp announced a quarterly cash dividend of $0.19 per share, payable on January 15, 2026, to shareholders of record as of January 2, 2026.
Company is reporting a consistent dividend payment, indicating financial stability and commitment to shareholder returns. They are also highlighted as the largest owner of inpatient rehabilitation hospitals in the United States with 171 hospitals across 39 states.
NegativeGlobeNewswire Inc.• Rosen Law Firm
EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims for Encompass Health shareholders following a New York Times article alleging serious patient safety incidents and below-average performance in rehabilitation hospitals.
Stock dropped 10.3% after New York Times article revealed serious patient harm incidents and below-average safety performance in rehabilitation hospitals
NegativeGlobeNewswire Inc.• Rosen Law Firm
EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm is investigating potential securities claims against Encompass Health Corporation following a New York Times article alleging serious patient safety issues in their rehabilitation hospitals.
The New York Times article reported rare but serious patient harm incidents and below-average safety measures in Encompass Health's rehabilitation hospitals, causing a 10.3% stock price drop and potential legal investigation
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal